VF
MDCO

Virtu Financial’s Medicines Co MDCO Stock Holding History

Virtu Financial’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.14M Buy
25,249
+18,495
+274% +$1.23M 0.21% 93
2019
Q3 		$338K Buy
+6,754
New +$269K 0.03% 686
2018
Q3 		– Sell
-7,797
Closed -$286K – 2492
2018
Q2 		$286K Buy
+7,797
New +$253K 0.02% 1193

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Virtu Financial's MDCO Position: Q4 2019 in Review

Virtu Financial increased its Medicines Co (MDCO) stake by 274% in Q4 2019, buying an estimated $1.23M and bringing the position to 25,249 shares worth $2.14M. The position accounts for 0.21% of the portfolio, ranked #93.

Virtu Financial first reported a position in MDCO in Q2 2018 and has held it in 3 quarters since. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Virtu Financial held 25,249 shares of Medicines Co worth $2.14M as of Q4 2019.
  • Virtu Financial bought 18,495 Medicines Co shares in Q4 2019, an estimated $1.23M.
  • Medicines Co made up 0.21% of Virtu Financial's portfolio in Q4 2019, its #93 holding.
  • Virtu Financial first reported a position in Medicines Co in Q2 2018 and has held it in 3 quarters since.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.